China Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The China Respiratory Devices Market is segmented by Type (Diagnostic and Monitoring Devices, Therapeutic Devices and Disposables). The report offers the value (in USD million) for the above segments.

Market Snapshot

Image 1_China Respiratory Devices Market
Study Period: 2019-2027
Base Year: 2021
CAGR: 12.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The China respiratory devices market is expected to register a CAGR of 12.5% over the forecast period.

COVID-19 had a significant impact on the China respiratory devices market. For instance, as per the article published in 2020 under the title “The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis”, there was a higher prevalence of COPD in individuals with severe presentations and worse outcomes, according to a large case series from China describing the clinical features and outcomes of patients with COVID-19. Furthermore, as per the article published in 2020 under the title “Clinical Characteristics of Coronavirus Disease 2019 in China”, out of 1099 patients studied, 5.0% were admitted to the ICU, and 2.3% underwent invasive mechanical ventilation. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). People utilized respiratory devices to improve their health conditions. Nebulizers, spirometers, and related respiratory devices were used at an increased rate during COVID-19. Furthermore, as per the article published in 2022 under the title "The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: Two years of the COVID-19 pandemic", in the post-COVID-19 period, the number of enrolled patients with acute respiratory tract infections (ARTI) and acute gastroenteritis (AGE) was dramatically reduced compared with that in the pre-COVID-19 period. The utilization of proper respiratory devices and the practice of nonpharmaceutical interventions (NPIs) such as social distancing, wearing masks, etc have changed the spread of COVID-19. Hence from the above-mentioned studies, COVID-19 had a significant impact on the China respiratory devices market.

The major factor broadly acting as a driving factor includes the high prevalence of respiratory diseases in China, the continuation of economic and demographic trends, technological advancements, and increasing applications in-home care settings. In China, chronic respiratory diseases are the second leading cause of death. For instance, as per the article published in 2021 under the title “Trend of Mortality and Years of Life Lost Due to Chronic Obstructive Pulmonary Disease in China and Its Provinces, 2005–2020”, COPD remains an important public health problem in China. Effective prevention and control measures were likely to strengthen to raise the standard of living for chronic obstructive pulmonary disease (COPD) patients and lower the number of COPD-related premature deaths among the Chinese population. Hence for that purpose, there is a high chance of adopting sophisticated respiratory devices within the population and which leads to market growth. The biggest preventable risk factors for the disease are cigarette smoking and air pollution and thus there are public-health priorities in China to reduce COPD-related diseases and deaths. Hence all these factors are expected to drive the overall market in China.

As per the aforesaid factors, China respiratory devices market is anticipated to grow over the forecast period. However, the high cost associated with respiratory devices is likely to restrain the market growth.

Scope of the Report

As per the scope of the report, respiratory devices refer to the supply of the respiratory gas mechanically to the patients with impaired respiratory function. The respiratory gas is usually enriched with oxygen and conveyed into the lung with a positive pressure generated by the device. The respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. The China Respiratory Devices Market is segmented by Type (Diagnostic and Monitoring Devices, Therapeutic Devices and Disposables). The report offers the value (in USD million) for the above segments.

By Type
Diagnostic and Monitoring Devices
Spirometers
Sleep Test Devices
Peak Flow Meters
Pulse Oximeters
Capnographs
Other Diagnostic and Monitoring Devices
Therapeutic Devices
CPAP Devices
BiPAP Devices
Humidifiers
Nebulizers
Oxygen Concentrators
Ventilators
Inhalers
Other Therapeutic Devices
Disposables
Masks
Breathing Circuits
Other Disposables

Report scope can be customized per your requirements. Click here.

Key Market Trends

Spirometers is Expected to be the Dominant Segment in Diagnostic and Monitoring Devices Over the Forecast Period

Spirometers help in diagnosing respiratory diseases, such as asthma, emphysema, bronchitis, and COPD. Furthermore, they can also be used to assess shortness of breath, lung function before surgery, and the effect of medication.

The spirometer segment has been fuelled by recent technological advancements, in the field of spirometry that includes the development of small portable spirometers and the increasing accuracy, acceptability, and reproducibility of assessments with immediate feedback to the technician. For instance, per the article published in August 2022 under the title “Automated interpretation of the pulmonary function test by a portable spirometer in Chinese adults”, the study investigated how accurately Chinese people’s pulmonary function test (PFT) obtained using a portable Yue Cloud spirometer when automatically interpreted. The study showed that the portable Yue Cloud spirometer can automatically interpret the PFT data in addition to providing accurate assessments of pulmonary function. Such innovative research studied to find out the efficiency of advanced spirometers is boosting the market growth in China.

Furthermore, the high prevalence of respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer in China is a major fueling factor for the respiratory device market. For instance, as per the International Agency for Research on Cancer, the number of new cases of Trachea, bronchus, and lung cancer in China was 816 thousand in 2020. The number is likely to be projected to be 1.35 million by 2040. This estimated high prevalence is an alarming factor for the population and people tend to adopt respiratory devices like spirometers in the coming future. 

Moreover, spirometers are used in the diagnosis and treatment of lung cancer which is likely to be a promoting factor for the market growth. For instance, as per the article published in May 2022 under the title "Spirometry at diagnosis and overall survival in non-small cell lung cancer patients", advanced stage lung cancer overall survival was linked to spirometry-detected COPD and more advanced COPD stages at diagnosis. The data showed that non-small cell lung cancer (NSCLC) patients' overall survival was likely to be enhanced by having a healthy pulmonary function upon diagnosis using a spirometer.

Thus, the applications of spirometers make it easier for the patient to use this diagnostic device and are also increasingly adopted in hospitals and home care. Hence the spirometer segment is likely to witness growth in the China respiratory devices market over the forecast period.

Estimated Number of New Trachea, Bronchus and Lung Cancer Cases, by Sex (in Million), China 2025-2040

Competitive Landscape

The China respiratory devices market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. Many companies are focusing on respiratory products across China. The companies are implementing certain strategic initiatives, such as a merger, new product launches, acquisitions, and partnerships that help them in strengthening their market position. The major players are Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Fisher & Paykel Healthcare Ltd, General Electric Company (GE Healthcare), and Nanjing Superstar Medical Equipment Co., Ltd among others.

Major Players

  1. Drägerwerk AG & Co. KGaA

  2. Teleflex Incorporated

  3. Fisher & Paykel Healthcare Ltd

  4. General Electric Company (GE Healthcare)

  5. Nanjing Superstar Medical Equipment Co., Ltd

China.png

Recent Development

  • In June 2022, AstraZeneca planned to build a manufacturing facility in Qingdao, China, to produce its Breztri aerosol inhalant COPD treatment, which was recently added to the country’s National Reimbursement Drug List.
  • In August 2021, Panasonic Corporation reported that Panasonic Ecology Systems Co., Ltd. (PES) and Panasonic Ecology Systems Guangdong Co., Ltd. built the First Shunde Branch Plant, a new factory for indoor air quality sensors (IAQ) devices such as energy recovery ventilator systems and air purifiers, in the Shunde District of the City of Foshan, Guangdong Province, China,

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, and Asthma

      2. 4.2.2 Technological Advancements and Increasing Applications in Homecare Setting

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Devices

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Type

      1. 5.1.1 Diagnostic and Monitoring Devices

        1. 5.1.1.1 Spirometers

        2. 5.1.1.2 Sleep Test Devices

        3. 5.1.1.3 Peak Flow Meters

        4. 5.1.1.4 Pulse Oximeters

        5. 5.1.1.5 Capnographs

        6. 5.1.1.6 Other Diagnostic and Monitoring Devices

      2. 5.1.2 Therapeutic Devices

        1. 5.1.2.1 CPAP Devices

        2. 5.1.2.2 BiPAP Devices

        3. 5.1.2.3 Humidifiers

        4. 5.1.2.4 Nebulizers

        5. 5.1.2.5 Oxygen Concentrators

        6. 5.1.2.6 Ventilators

        7. 5.1.2.7 Inhalers

        8. 5.1.2.8 Other Therapeutic Devices

      3. 5.1.3 Disposables

        1. 5.1.3.1 Masks

        2. 5.1.3.2 Breathing Circuits

        3. 5.1.3.3 Other Disposables

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Teleflex Incorporated

      2. 6.1.2 Drägerwerk AG & Co. KGaA

      3. 6.1.3 Fisher & Paykel Healthcare Ltd

      4. 6.1.4 General Electric Company (GE Healthcare)

      5. 6.1.5 Nanjing Superstar Medical Equipment Co., Ltd

      6. 6.1.6 Koninklijke Philips NV

      7. 6.1.7 Medtronic PLC

      8. 6.1.8 ResMed Inc.

      9. 6.1.9 CHANGZHOU ZHENGYUAN MEDICAL TECHNOLOGY CO. LTD.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The China Respiratory Devices Market market is studied from 2019 - 2027.

The China Respiratory Devices Market is growing at a CAGR of 12.5% over the next 5 years.

Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Fisher & Paykel Healthcare Ltd, General Electric Company (GE Healthcare), Nanjing Superstar Medical Equipment Co., Ltd are the major companies operating in China Respiratory Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!